<DOC>
	<DOCNO>NCT00163514</DOCNO>
	<brief_summary>The purpose study investigate safety effectiveness ciclesonide nasal spray compare placebo ( inactive substance ) nasal spray relieve symptom perennial allergic rhinitis .</brief_summary>
	<brief_title>Safety Effectiveness Ciclesonide Nasal Spray Children ( 6 11 Years ) With Perennial Allergic Rhinitis ( BY9010/M1-403 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main General good health , perennial allergic rhinitis History diagnosis perennial allergic rhinitis skin prick test Parent/caregiver must capable understanding requirement , risk , benefit study participation , , judge investigator , capable give informed consent comply study requirement ( visit , recordkeeping , etc . ) Main Participation investigational drug trial within 30 day precede Screening Visit time trial Use prohibit concomitant medication define study protocol Nonvaccinated exposure , active infection , chickenpox measles within 21 day precede Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Perennial Allergic Rhinitis</keyword>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Hay Fever</keyword>
</DOC>